Advanced Search (OLGA)

Gene: AGPAT4 (1-acylglycerol-3-phosphate O-acyltransferase 4) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

AGPAT4

Name:

1-acylglycerol-3-phosphate O-acyltransferase 4

RGD ID:

1354001

HGNC Page

HGNC:20885

Description:

Predicted to enable 1-acylglycerol-3-phosphate O-acyltransferase activity. Predicted to be involved in phosphatidic acid biosynthetic process. Predicted to be located in endoplasmic reticulum. Predicted to be active in endomembrane system and mitochondrial outer membrane.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

1-acyl-sn-glycerol-3-phosphate acyltransferase delta; 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta); 1-AGP acyltransferase 4; 1-AGPAT 4; 1-AGPAT4; dJ473J16.2; LPAAT-delta; LPAAT4; LPLAT4; lysophosphatidic acid acyltransferase delta; lysophosphatidic acid acyltransferase-delta (LPAAT-delta); lysophospholipid acyltransferase 4; RP3-473J16.2

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	6	161,129,967 - 161,274,061 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	6	161,129,967 - 161,274,061 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	6	161,550,999 - 161,695,093 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	6	161,471,047 - 161,615,097 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	6	161,527,517 - 161,665,448	NCBI
Celera	6	162,280,457 - 162,424,409 (-)	NCBI		Celera
Cytogenetic Map	6	q26	NCBI
HuRef	6	159,006,418 - 159,150,408 (-)	NCBI		HuRef
CHM1_1	6	161,813,702 - 161,957,597 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	6	162,488,365 - 162,632,384 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGPAT4	Human	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: 3-methylglutaconic aciduria with deafness more ...	ClinVar	PMID:15220921 more ...

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGPAT4	Human	1,2-dimethylhydrazine	decreases expression	ISO	Agpat4 (Mus musculus)	6480464	1 and 2-Dimethylhydrazine results in decreased expression of AGPAT4 mRNA	CTD	PMID:22206623
AGPAT4	Human	1,2-dimethylhydrazine	multiple interactions	ISO	Agpat4 (Mus musculus)	6480464	[1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AGPAT4 mRNA	CTD	PMID:22206623
AGPAT4	Human	17alpha-ethynylestradiol	multiple interactions	ISO	Agpat4 (Mus musculus)	6480464	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGPAT4 mRNA	CTD	PMID:17942748
AGPAT4	Human	17beta-estradiol	multiple interactions	EXP		6480464	[Progesterone co-treated with Estradiol] results in decreased expression of AGPAT4 mRNA	CTD	PMID:17404688
AGPAT4	Human	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	Agpat4 (Mus musculus)	6480464	2 more ...	CTD	PMID:20005886
AGPAT4	Human	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	Agpat4 (Mus musculus)	6480464	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGPAT4 mRNA	CTD	PMID:17942748
AGPAT4	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin results in increased expression of AGPAT4 mRNA	CTD	PMID:33387578
AGPAT4	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin results in decreased expression of AGPAT4 mRNA	CTD	PMID:34747641
AGPAT4	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	Agpat4 (Mus musculus)	6480464	Tetrachlorodibenzodioxin results in increased expression of AGPAT4 mRNA	CTD	PMID:28238261
AGPAT4	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	Agpat4 (Mus musculus)	6480464	Tetrachlorodibenzodioxin results in decreased expression of AGPAT4 mRNA	CTD	PMID:21354282
AGPAT4	Human	2-hydroxypropanoic acid	decreases expression	EXP		6480464	Lactic Acid results in decreased expression of AGPAT4 mRNA	CTD	PMID:30851411
AGPAT4	Human	2-methylcholine	affects expression	EXP		6480464	beta-methylcholine affects the expression of AGPAT4 mRNA	CTD	PMID:21179406
AGPAT4	Human	4,4'-sulfonyldiphenol	multiple interactions	EXP		6480464	[bisphenol S co-treated with Fulvestrant] results in increased methylation of AGPAT4 gene	CTD	PMID:31601247
AGPAT4	Human	4,4'-sulfonyldiphenol	multiple interactions	ISO	Agpat4 (Rattus norvegicus)	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGPAT4 mRNA	CTD	PMID:36041667
AGPAT4	Human	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	increases expression	EXP		6480464	Am 580 results in increased expression of AGPAT4 mRNA	CTD	PMID:16982809
AGPAT4	Human	4-hydroxyphenyl retinamide	decreases expression	ISO	Agpat4 (Mus musculus)	6480464	Fenretinide results in decreased expression of AGPAT4 mRNA	CTD	PMID:28973697
AGPAT4	Human	acetamide	increases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	acetamide results in increased expression of AGPAT4 mRNA	CTD	PMID:31881176
AGPAT4	Human	all-trans-retinoic acid	decreases expression	EXP		6480464	Tretinoin results in decreased expression of AGPAT4 mRNA	CTD	PMID:33167477
AGPAT4	Human	ammonium chloride	affects expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Ammonium Chloride affects the expression of AGPAT4 mRNA	CTD	PMID:16483693
AGPAT4	Human	aristolochic acid A	decreases expression	EXP		6480464	aristolochic acid I results in decreased expression of AGPAT4 mRNA	CTD	PMID:33212167
AGPAT4	Human	arsenous acid	increases expression	EXP		6480464	Arsenic Trioxide results in increased expression of AGPAT4 mRNA	CTD	PMID:21461292
AGPAT4	Human	benzo[a]pyrene	decreases expression	EXP		6480464	Benzo(a)pyrene results in decreased expression of AGPAT4 mRNA	CTD	PMID:20064835
AGPAT4	Human	benzo[a]pyrene	decreases methylation	EXP		6480464	Benzo(a)pyrene results in decreased methylation of AGPAT4 promoter	CTD	PMID:27901495
AGPAT4	Human	benzo[a]pyrene	increases expression	ISO	Agpat4 (Mus musculus)	6480464	Benzo(a)pyrene results in increased expression of AGPAT4 mRNA	CTD	PMID:32417428
AGPAT4	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of AGPAT4 5' UTR	CTD	PMID:27901495
AGPAT4	Human	benzo[a]pyrene diol epoxide I	decreases expression	EXP		6480464	7 more ...	CTD	PMID:20382639
AGPAT4	Human	bis(2-ethylhexyl) phthalate	decreases expression	EXP		6480464	Diethylhexyl Phthalate results in decreased expression of AGPAT4 mRNA	CTD	PMID:31163220
AGPAT4	Human	bis(2-ethylhexyl) phthalate	decreases expression	ISO	Agpat4 (Mus musculus)	6480464	Diethylhexyl Phthalate results in decreased expression of AGPAT4 mRNA	CTD	PMID:34319233
AGPAT4	Human	bisphenol A	decreases expression	EXP		6480464	bisphenol A results in decreased expression of AGPAT4 mRNA	CTD	PMID:25047013
AGPAT4	Human	bisphenol A	multiple interactions	ISO	Agpat4 (Rattus norvegicus)	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGPAT4 mRNA	CTD	PMID:36041667
AGPAT4	Human	bisphenol A	affects methylation	EXP		6480464	bisphenol A affects the methylation of AGPAT4 gene	CTD	PMID:31601247
AGPAT4	Human	bisphenol A	decreases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	bisphenol A results in decreased expression of AGPAT4 mRNA	CTD	PMID:30816183 and PMID:34947998
AGPAT4	Human	bisphenol A	affects expression	ISO	Agpat4 (Rattus norvegicus)	6480464	bisphenol A affects the expression of AGPAT4 mRNA	CTD	PMID:25181051
AGPAT4	Human	bisphenol A	decreases expression	ISO	Agpat4 (Mus musculus)	6480464	bisphenol A results in decreased expression of AGPAT4 mRNA	CTD	PMID:26063408
AGPAT4	Human	bisphenol F	multiple interactions	ISO	Agpat4 (Rattus norvegicus)	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGPAT4 mRNA	CTD	PMID:36041667
AGPAT4	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to AGPAT4 gene]	CTD	PMID:28238834
AGPAT4	Human	choline	multiple interactions	ISO	Agpat4 (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AGPAT4 mRNA	CTD	PMID:20938992
AGPAT4	Human	cisplatin	decreases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Cisplatin results in decreased expression of AGPAT4 mRNA	CTD	PMID:22023808
AGPAT4	Human	cisplatin	multiple interactions	EXP		6480464	[Cisplatin co-treated with jinfukang] results in decreased expression of AGPAT4 mRNA	CTD	PMID:27392435
AGPAT4	Human	copper(II) chloride	decreases expression	EXP		6480464	cupric chloride results in decreased expression of AGPAT4 mRNA	CTD	PMID:38568856
AGPAT4	Human	copper(II) sulfate	increases expression	EXP		6480464	Copper Sulfate results in increased expression of AGPAT4 mRNA	CTD	PMID:19549813
AGPAT4	Human	crocidolite asbestos	decreases expression	ISO	Agpat4 (Mus musculus)	6480464	Asbestos and Crocidolite results in decreased expression of AGPAT4 mRNA	CTD	PMID:29279043
AGPAT4	Human	Cuprizon	decreases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Cuprizone results in decreased expression of AGPAT4 mRNA	CTD	PMID:27523638
AGPAT4	Human	dexamethasone	decreases expression	EXP		6480464	Dexamethasone results in decreased expression of AGPAT4 mRNA	CTD	PMID:25047013
AGPAT4	Human	diarsenic trioxide	increases expression	EXP		6480464	Arsenic Trioxide results in increased expression of AGPAT4 mRNA	CTD	PMID:21461292
AGPAT4	Human	Dibutyl phosphate	affects expression	EXP		6480464	di-n-butylphosphoric acid affects the expression of AGPAT4 mRNA	CTD	PMID:37042841
AGPAT4	Human	doxorubicin	decreases expression	EXP		6480464	Doxorubicin results in decreased expression of AGPAT4 mRNA	CTD	PMID:29803840
AGPAT4	Human	endosulfan	decreases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Endosulfan results in decreased expression of AGPAT4 mRNA	CTD	PMID:29391264
AGPAT4	Human	ethanol	increases expression	ISO	Agpat4 (Mus musculus)	6480464	Ethanol results in increased expression of AGPAT4 mRNA	CTD	PMID:19167417
AGPAT4	Human	folic acid	multiple interactions	ISO	Agpat4 (Mus musculus)	6480464	[1 more ...	CTD	PMID:20938992 and PMID:22206623
AGPAT4	Human	fulvestrant	multiple interactions	EXP		6480464	[bisphenol S co-treated with Fulvestrant] results in increased methylation of AGPAT4 gene	CTD	PMID:31601247
AGPAT4	Human	furan	increases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	furan results in increased expression of AGPAT4 mRNA	CTD	PMID:27387713
AGPAT4	Human	gentamycin	decreases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Gentamicins results in decreased expression of AGPAT4 mRNA	CTD	PMID:22061828
AGPAT4	Human	gentamycin	increases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Gentamicins results in increased expression of AGPAT4 mRNA	CTD	PMID:33387578
AGPAT4	Human	indometacin	increases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Indomethacin results in increased expression of AGPAT4 mRNA	CTD	PMID:36868495
AGPAT4	Human	irinotecan	affects expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Irinotecan affects the expression of AGPAT4 mRNA	CTD	PMID:20097248
AGPAT4	Human	L-methionine	multiple interactions	ISO	Agpat4 (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AGPAT4 mRNA	CTD	PMID:20938992
AGPAT4	Human	methylmercury chloride	decreases expression	EXP		6480464	methylmercuric chloride results in decreased expression of AGPAT4 mRNA	CTD	PMID:28001369
AGPAT4	Human	oxaliplatin	multiple interactions	ISO	Agpat4 (Rattus norvegicus)	6480464	[oxaliplatin co-treated with Topotecan] results in increased expression of AGPAT4 mRNA	CTD	PMID:25729387
AGPAT4	Human	paracetamol	affects expression	ISO	Agpat4 (Mus musculus)	6480464	Acetaminophen affects the expression of AGPAT4 mRNA	CTD	PMID:17562736
AGPAT4	Human	potassium chromate	decreases expression	EXP		6480464	potassium chromate(VI) results in decreased expression of AGPAT4 mRNA	CTD	PMID:22714537
AGPAT4	Human	progesterone	multiple interactions	EXP		6480464	[Progesterone co-treated with Estradiol] results in decreased expression of AGPAT4 mRNA	CTD	PMID:17404688
AGPAT4	Human	rac-lactic acid	decreases expression	EXP		6480464	Lactic Acid results in decreased expression of AGPAT4 mRNA	CTD	PMID:30851411
AGPAT4	Human	resveratrol	increases expression	ISO	Agpat4 (Mus musculus)	6480464	resveratrol results in increased expression of AGPAT4 protein	CTD	PMID:25505154
AGPAT4	Human	silicon dioxide	decreases expression	EXP		6480464	Silicon Dioxide analog results in decreased expression of AGPAT4 mRNA	CTD	PMID:25895662
AGPAT4	Human	sodium arsenite	affects methylation	EXP		6480464	sodium arsenite affects the methylation of AGPAT4 gene	CTD	PMID:28589171
AGPAT4	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of AGPAT4 mRNA	CTD	PMID:38568856
AGPAT4	Human	tetracycline	decreases expression	ISO	Agpat4 (Mus musculus)	6480464	Tetracycline results in decreased expression of AGPAT4 mRNA	CTD	PMID:16917069
AGPAT4	Human	thioacetamide	increases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Thioacetamide results in increased expression of AGPAT4 mRNA	CTD	PMID:34492290
AGPAT4	Human	topotecan	multiple interactions	ISO	Agpat4 (Rattus norvegicus)	6480464	[oxaliplatin co-treated with Topotecan] results in increased expression of AGPAT4 mRNA	CTD	PMID:25729387
AGPAT4	Human	topotecan	increases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	Topotecan results in increased expression of AGPAT4 mRNA	CTD	PMID:25729387
AGPAT4	Human	triptonide	decreases expression	ISO	Agpat4 (Mus musculus)	6480464	triptonide results in decreased expression of AGPAT4 mRNA	CTD	PMID:33045310
AGPAT4	Human	valproic acid	increases expression	EXP		6480464	Valproic Acid results in increased expression of AGPAT4 mRNA	CTD	PMID:29154799
AGPAT4	Human	valproic acid	decreases expression	EXP		6480464	Valproic Acid results in decreased expression of AGPAT4 mRNA	CTD	PMID:23179753 and PMID:28001369
AGPAT4	Human	valproic acid	affects expression	EXP		6480464	Valproic Acid affects the expression of AGPAT4 mRNA	CTD	PMID:25979313
AGPAT4	Human	vinclozolin	decreases expression	ISO	Agpat4 (Rattus norvegicus)	6480464	vinclozolin results in decreased expression of AGPAT4 mRNA	CTD	PMID:23034163

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGPAT4	Human	CDP-diacylglycerol biosynthetic process	involved_in	IEA	UniPathway:UPA00557	150520179		UniProt	GO_REF:0000041
AGPAT4	Human	lipid metabolic process	involved_in	IEA	UniProtKB-KW:KW-0443	150520179		UniProt	GO_REF:0000043
AGPAT4	Human	phosphatidic acid biosynthetic process	involved_in	TAS		150520179		Reactome	Reactome:R-HSA-1483166
AGPAT4	Human	phospholipid biosynthetic process	involved_in	NAS		150520179	PMID:15367102	UniProt	PMID:15367102
AGPAT4	Human	phospholipid biosynthetic process	involved_in	IEA	UniProtKB-KW:KW-0594	150520179		UniProt	GO_REF:0000043
AGPAT4	Human	phospholipid metabolic process	involved_in	IEA	UniProtKB:Q8K4X7 and ensembl:ENSMUSP00000024594	150520179		Ensembl	GO_REF:0000107

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGPAT4	Human	endomembrane system	is_active_in	IBA	MGI:1336186 more ...	150520179		GO_Central	GO_REF:0000033
AGPAT4	Human	endoplasmic reticulum	located_in	IEA	UniProtKB-KW:KW-0256	150520179		UniProt	GO_REF:0000043
AGPAT4	Human	endoplasmic reticulum	located_in	ISS	UniProtKB:Q8K4X7	150520179		UniProt	GO_REF:0000024
AGPAT4	Human	endoplasmic reticulum	located_in	IEA	UniProtKB:Q8K4X7 and ensembl:ENSMUSP00000024594	150520179		Ensembl	GO_REF:0000107
AGPAT4	Human	endoplasmic reticulum membrane	located_in	IEA	UniProtKB-SubCell:SL-0097	150520179		UniProt	GO_REF:0000044
AGPAT4	Human	endoplasmic reticulum membrane	located_in	IEA	ARBA:ARBA00028685	150520179		UniProt	GO_REF:0000117
AGPAT4	Human	endoplasmic reticulum membrane	located_in	TAS		150520179		Reactome	Reactome:R-HSA-75885
AGPAT4	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
AGPAT4	Human	mitochondrial outer membrane	is_active_in	IEA	UniProtKB:Q8K4X7 and ensembl:ENSMUSP00000024594	150520179		Ensembl	GO_REF:0000107
AGPAT4	Human	mitochondrial outer membrane	is_active_in	IBA	MGI:1915512 and PANTHER:PTN002590791	150520179		GO_Central	GO_REF:0000033

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGPAT4	Human	1-acylglycerol-3-phosphate O-acyltransferase activity	enables	IEA	UniProtKB:Q8K4X7 and ensembl:ENSMUSP00000024594	150520179		Ensembl	GO_REF:0000107
AGPAT4	Human	1-acylglycerol-3-phosphate O-acyltransferase activity	enables	IBA	MGI:1915512 more ...	150520179		GO_Central	GO_REF:0000033
AGPAT4	Human	1-acylglycerol-3-phosphate O-acyltransferase activity	enables	IEA	RHEA:19709	150520179		RHEA	GO_REF:0000116
AGPAT4	Human	1-acylglycerol-3-phosphate O-acyltransferase activity	enables	TAS		150520179		Reactome	Reactome:R-HSA-75885
AGPAT4	Human	1-acylglycerol-3-phosphate O-acyltransferase activity	enables	IEA	EC:2.3.1.51	150520179		UniProt	GO_REF:0000003
AGPAT4	Human	1-acylglycerol-3-phosphate O-acyltransferase activity	enables	ISS	UniProtKB:Q8K4X7	150520179		UniProt	GO_REF:0000024
AGPAT4	Human	1-acylglycerol-3-phosphate O-acyltransferase activity	enables	NAS		150520179	PMID:15367102	UniProt	PMID:15367102
AGPAT4	Human	acyltransferase activity	enables	IEA	UniProtKB-KW:KW-0012	150520179		UniProt	GO_REF:0000043
AGPAT4	Human	acyltransferase activity	enables	IEA	InterPro:IPR002123	150520179		InterPro	GO_REF:0000002
AGPAT4	Human	lysophosphatidic acid acyltransferase activity	enables	IEA	UniProtKB:Q8K4X7 and ensembl:ENSMUSP00000024594	150520179		Ensembl	GO_REF:0000107
AGPAT4	Human	protein binding	enables	IPI	UniProtKB:Q04864	150520179	PMID:25416956	IntAct	PMID:25416956
AGPAT4	Human	protein binding	enables	IPI	UniProtKB:A6NM10-2 more ...	150520179	PMID:32296183	IntAct	PMID:32296183
AGPAT4	Human	transferase activity	enables	IEA	UniProtKB-KW:KW-0808	150520179		UniProt	GO_REF:0000043

Imported Annotations - KEGG (archival)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
AGPAT4	Human	glycerophospholipid metabolic pathway		IEA		6907045		KEGG	hsa:00564

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	KEGG Annotation Import Pipeline	Pipeline to import KEGG annotations from KEGG into RGD
3.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
4.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:9828130	PMID:11487472	PMID:12477932	PMID:12975309	PMID:14574404	PMID:15367102	PMID:15489334	PMID:17207965	PMID:17474147	PMID:20379614	PMID:21873635	PMID:24047446
PMID:25416956	PMID:26186194	PMID:26417903	PMID:28514442	PMID:30833792	PMID:31796584	PMID:31980649	PMID:32296017	PMID:32296183	PMID:32513696	PMID:32707033	PMID:33961781
PMID:34709727	PMID:36114006	PMID:36215168	PMID:36897256	PMID:36949045	PMID:37314216

AGPAT4
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	6	161,129,967 - 161,274,061 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	6	161,129,967 - 161,274,061 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	6	161,550,999 - 161,695,093 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	6	161,471,047 - 161,615,097 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	6	161,527,517 - 161,665,448	NCBI
Celera	6	162,280,457 - 162,424,409 (-)	NCBI		Celera
Cytogenetic Map	6	q26	NCBI
HuRef	6	159,006,418 - 159,150,408 (-)	NCBI		HuRef
CHM1_1	6	161,813,702 - 161,957,597 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	6	162,488,365 - 162,632,384 (-)	NCBI		T2T-CHM13v2.0

Agpat4
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	17	12,337,372 - 12,438,536 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	17	12,337,591 - 12,438,532 (+)	Ensembl		GRCm39 Ensembl
GRCm38	17	12,118,485 - 12,219,649 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	17	12,118,704 - 12,219,645 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	17	12,312,150 - 12,412,506 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	17	11,962,642 - 12,062,998 (+)	NCBI		MGSCv36	mm8
Celera	17	12,147,922 - 12,252,652 (+)	NCBI		Celera
Cytogenetic Map	17	A1	NCBI
cM Map	17	8.33	NCBI

Agpat4
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	1	51,075,081 - 51,181,548 (-)	NCBI		GRCr8
mRatBN7.2	1	48,525,131 - 48,633,798 (-)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	1	48,527,323 - 48,633,345 (-)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	1	49,218,910 - 49,324,839 (-)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	1	55,203,981 - 55,309,606 (-)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	1	49,294,411 - 49,400,333 (-)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	1	48,716,094 - 48,826,292 (-)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	1	48,719,633 - 48,825,364 (-)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	1	50,929,133 - 51,035,499 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	1	42,986,809 - 43,096,390 (-)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	1	42,989,754 - 43,099,335 (-)	NCBI
Celera	1	44,317,112 - 44,422,634 (-)	NCBI		Celera
Cytogenetic Map	1	q11	NCBI

Agpat4
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955439	20,050,619 - 20,132,893 (+)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955439	20,050,619 - 20,132,893 (+)	NCBI	ChiLan1.0	ChiLan1.0

AGPAT4
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	5	181,305,186 - 181,450,074 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	6	179,210,769 - 179,355,480 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	6	159,075,360 - 159,219,887 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	6	164,085,970 - 164,229,696 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	6	164,092,522 - 164,229,696 (-)	Ensembl	panpan1.1		panPan2

AGPAT4
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	1	49,709,437 - 49,837,848 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	1	49,709,741 - 49,837,091 (-)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	1	50,552,643 - 50,680,914 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	1	49,894,606 - 50,022,389 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	1	49,894,612 - 50,023,044 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	1	49,776,903 - 49,904,869 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	1	49,647,989 - 49,776,147 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	1	50,264,213 - 50,392,536 (-)	NCBI		UU_Cfam_GSD_1.0

Agpat4
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024404946	144,730,179 - 144,826,056 (-)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936489	11,981,969 - 12,042,447 (-)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936489	11,982,488 - 12,078,132 (-)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

AGPAT4
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	1	6,772,417 - 6,883,551 (+)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	1	6,761,734 - 6,883,555 (+)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	1	8,330,534 - 8,440,346 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

AGPAT4
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	13	88,634,100 - 88,782,371 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	13	88,640,548 - 88,781,702 (-)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666040	60,965,050 - 61,111,779 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Agpat4
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624855	2,046,014 - 2,161,398 (+)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624855	2,046,000 - 2,185,729 (+)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in AGPAT4
39 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 6q24.1-27(chr6:141132990-169339571)x3	copy number gain	See cases [RCV000050604]	Chr6:141132990..169339571 [GRCh38] Chr6:141454127..169739666 [GRCh37] Chr6:141495820..169481591 [NCBI36] Chr6:6q24.1-27	pathogenic
GRCh38/hg38 6q25.2-27(chr6:152376338-170583214)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051902]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051902]\|See cases [RCV000051902]	Chr6:152376338..170583214 [GRCh38] Chr6:152697473..170892302 [GRCh37] Chr6:152739166..170734227 [NCBI36] Chr6:6q25.2-27	pathogenic
GRCh38/hg38 6q25.3-27(chr6:158664768-170612001)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051904]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051904]\|See cases [RCV000051904]	Chr6:158664768..170612001 [GRCh38] Chr6:159085800..170921089 [GRCh37] Chr6:159005788..170763014 [NCBI36] Chr6:6q25.3-27	pathogenic
GRCh38/hg38 6q25.2-27(chr6:154118058-170602152)x1	copy number loss	See cases [RCV000052207]	Chr6:154118058..170602152 [GRCh38] Chr6:154439193..170911240 [GRCh37] Chr6:154480885..170753165 [NCBI36] Chr6:6q25.2-27	pathogenic
GRCh38/hg38 6q25.3-27(chr6:159454639-170612001)x1	copy number loss	See cases [RCV000052209]	Chr6:159454639..170612001 [GRCh38] Chr6:159875671..170921089 [GRCh37] Chr6:159795661..170763014 [NCBI36] Chr6:6q25.3-27	pathogenic
GRCh38/hg38 6q25.3-27(chr6:159825913-170612001)x1	copy number loss	See cases [RCV000052211]	Chr6:159825913..170612001 [GRCh38] Chr6:160246945..170921089 [GRCh37] Chr6:160166935..170763014 [NCBI36] Chr6:6q25.3-27	pathogenic
GRCh38/hg38 6q25.3-27(chr6:160328288-170612001)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052212]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052212]\|See cases [RCV000052212]	Chr6:160328288..170612001 [GRCh38] Chr6:160749320..170921089 [GRCh37] Chr6:160669310..170763014 [NCBI36] Chr6:6q25.3-27	pathogenic
GRCh38/hg38 6q25.3-27(chr6:160359686-170608818)x1	copy number loss	See cases [RCV000052213]	Chr6:160359686..170608818 [GRCh38] Chr6:160780718..170917906 [GRCh37] Chr6:160700708..170759831 [NCBI36] Chr6:6q25.3-27	pathogenic
GRCh38/hg38 6q25.3-27(chr6:160422761-170612001)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052214]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052214]\|See cases [RCV000052214]	Chr6:160422761..170612001 [GRCh38] Chr6:160843793..170921089 [GRCh37] Chr6:160763783..170763014 [NCBI36] Chr6:6q25.3-27	pathogenic
GRCh38/hg38 6q26-27(chr6:161205328-170581161)x1	copy number loss	See cases [RCV000052215]	Chr6:161205328..170581161 [GRCh38] Chr6:161626360..170890249 [GRCh37] Chr6:161546350..170732174 [NCBI36] Chr6:6q26-27	pathogenic
NM_020133.2(AGPAT4):c.348+4780G>A	single nucleotide variant	Malignant melanoma [RCV000067207]	Chr6:161161468 [GRCh38] Chr6:161582500 [GRCh37] Chr6:161502490 [NCBI36] Chr6:6q26	not provided
GRCh38/hg38 6q25.3-27(chr6:160484810-170612011)x1	copy number loss	See cases [RCV000134021]	Chr6:160484810..170612011 [GRCh38] Chr6:160905842..170921099 [GRCh37] Chr6:160825832..170763024 [NCBI36] Chr6:6q25.3-27	pathogenic
GRCh38/hg38 6q26(chr6:161232208-161348695)x3	copy number gain	See cases [RCV000135870]	Chr6:161232208..161348695 [GRCh38] Chr6:161653240..161769727 [GRCh37] Chr6:161573230..161689717 [NCBI36] Chr6:6q26	benign
GRCh38/hg38 6q25.2-27(chr6:154539655-170714507)x1	copy number loss	See cases [RCV000137381]	Chr6:154539655..170714507 [GRCh38] Chr6:154860789..171023595 [GRCh37] Chr6:154902481..170865520 [NCBI36] Chr6:6q25.2-27	pathogenic
GRCh38/hg38 6q25.3-26(chr6:155378049-163133499)x1	copy number loss	See cases [RCV000137831]	Chr6:155378049..163133499 [GRCh38] Chr6:155699183..163554531 [GRCh37] Chr6:155740875..163474521 [NCBI36] Chr6:6q25.3-26	pathogenic
GRCh38/hg38 6q25.3-27(chr6:159915390-170714507)x1	copy number loss	See cases [RCV000139636]	Chr6:159915390..170714507 [GRCh38] Chr6:160336422..171023595 [GRCh37] Chr6:160256412..170865520 [NCBI36] Chr6:6q25.3-27	pathogenic
GRCh38/hg38 6q25.2-27(chr6:152793402-170610394)x1	copy number loss	See cases [RCV000141880]	Chr6:152793402..170610394 [GRCh38] Chr6:153114537..170919482 [GRCh37] Chr6:153156230..170761407 [NCBI36] Chr6:6q25.2-27	pathogenic
GRCh38/hg38 6q25.2-27(chr6:152376338-170612001)x3	copy number gain	See cases [RCV000142594]	Chr6:152376338..170612001 [GRCh38] Chr6:152697473..170921089 [GRCh37] Chr6:152739166..170763014 [NCBI36] Chr6:6q25.2-27	pathogenic
GRCh38/hg38 6q26(chr6:160892889-161535434)x3	copy number gain	See cases [RCV000143355]	Chr6:160892889..161535434 [GRCh38] Chr6:161313921..161956466 [GRCh37] Chr6:161233911..161876456 [NCBI36] Chr6:6q26	uncertain significance
GRCh38/hg38 6q23.2-27(chr6:133537271-165875545)x3	copy number gain	See cases [RCV000143444]	Chr6:133537271..165875545 [GRCh38] Chr6:133858409..166289033 [GRCh37] Chr6:133900102..166209023 [NCBI36] Chr6:6q23.2-27	pathogenic
GRCh38/hg38 6q26-27(chr6:160899898-170610394)x1	copy number loss	See cases [RCV000143619]	Chr6:160899898..170610394 [GRCh38] Chr6:161320930..170919482 [GRCh37] Chr6:161240920..170761407 [NCBI36] Chr6:6q26-27	pathogenic
NC_000006.12:g.160931666_161145877dup	duplication	Normal pregnancy [RCV000161459]	Chr6:160931666..161145877 [GRCh38] Chr6:161352698..161566909 [GRCh37] Chr6:6q26	not provided
GRCh37/hg19 6q26(chr6:161625929-161812380)x4	copy number gain	See cases [RCV000239818]	Chr6:161625929..161812380 [GRCh37] Chr6:6q26	uncertain significance
GRCh37/hg19 6q25.3-27(chr6:159006336-170713678)x3	copy number gain	not provided [RCV003312672]	Chr6:159006336..170713678 [GRCh37] Chr6:6q25.3-27	uncertain significance
GRCh37/hg19 6q25.1-27(chr6:151214792-170892243)x3	copy number gain	See cases [RCV000449011]	Chr6:151214792..170892243 [GRCh37] Chr6:6q25.1-27	pathogenic
GRCh37/hg19 6q26(chr6:161381865-161557137)x3	copy number gain	See cases [RCV000448225]	Chr6:161381865..161557137 [GRCh37] Chr6:6q26	uncertain significance
GRCh37/hg19 6p25.3-q27(chr6:156975-170919482)x3	copy number gain	See cases [RCV000512067]	Chr6:156975..170919482 [GRCh37] Chr6:6p25.3-q27	pathogenic
GRCh37/hg19 6p25.3-q27(chr6:156975-170919482)	copy number gain	See cases [RCV000510595]	Chr6:156975..170919482 [GRCh37] Chr6:6p25.3-q27	pathogenic
GRCh37/hg19 6q25.3-26(chr6:160524800-161855470)x3	copy number gain	not provided [RCV000682735]	Chr6:160524800..161855470 [GRCh37] Chr6:6q25.3-26	uncertain significance
GRCh37/hg19 6q25.3-27(chr6:159844762-170919482)x3	copy number gain	not provided [RCV000682734]	Chr6:159844762..170919482 [GRCh37] Chr6:6q25.3-27	pathogenic
46,XX,der(6)(q25.1,q28)dn.seq[GRCh37/hg19]der(6)(6pter->6q25.2(+)(154768571)::q25.2(+)(154778901),q25.2(+)154778992::q25.2(-)(154774048),q25.2(-)(154768571)::q25.2(-)(154768571),q25.1(-)(~151443183-151443483))dn	complex	Coffin-Siris syndrome 1 [RCV000714957]	Chr6:151443333..171115067 [GRCh37] Chr6:6q25.1-27	pathogenic
GRCh37/hg19 6p25.3-q27(chr6:108666-170980171)x3	copy number gain	not provided [RCV000745403]	Chr6:108666..170980171 [GRCh37] Chr6:6p25.3-q27	pathogenic
GRCh37/hg19 6p25.3-q27(chr6:60107-171054786)x3	copy number gain	not provided [RCV000745400]	Chr6:60107..171054786 [GRCh37] Chr6:6p25.3-q27	pathogenic
GRCh37/hg19 6p25.3-q27(chr6:165632-170919470)x3	copy number gain	not provided [RCV000745404]	Chr6:165632..170919470 [GRCh37] Chr6:6p25.3-q27	pathogenic
GRCh37/hg19 6q25.1-27(chr6:150284435-170919470)x3	copy number gain	not provided [RCV000746100]	Chr6:150284435..170919470 [GRCh37] Chr6:6q25.1-27	pathogenic
GRCh37/hg19 6q25.3-27(chr6:159155998-171054786)x3	copy number gain	not provided [RCV000746132]	Chr6:159155998..171054786 [GRCh37] Chr6:6q25.3-27	pathogenic
GRCh37/hg19 6q26(chr6:161323288-162845262)x3	copy number gain	not provided [RCV000746146]	Chr6:161323288..162845262 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.872C>T (p.Thr291Met)	single nucleotide variant	not specified [RCV004294423]	Chr6:161139592 [GRCh38] Chr6:161560624 [GRCh37] Chr6:6q26	uncertain significance
GRCh37/hg19 6q26(chr6:161069025-161747332)x3	copy number gain	not provided [RCV001258763]	Chr6:161069025..161747332 [GRCh37] Chr6:6q26	uncertain significance
GRCh37/hg19 6q26(chr6:161593323-161814295)x3	copy number gain	not provided [RCV001258767]	Chr6:161593323..161814295 [GRCh37] Chr6:6q26	uncertain significance
GRCh37/hg19 6q25.3-26(chr6:160778308-161898925)	copy number gain	not specified [RCV002053650]	Chr6:160778308..161898925 [GRCh37] Chr6:6q25.3-26	uncertain significance
GRCh37/hg19 6q25.2-26(chr6:153207930-164322346)	copy number loss	not specified [RCV002053640]	Chr6:153207930..164322346 [GRCh37] Chr6:6q25.2-26	pathogenic
GRCh37/hg19 6q26-27(chr6:161047873-170919482)	copy number loss	not specified [RCV002053651]	Chr6:161047873..170919482 [GRCh37] Chr6:6q26-27	pathogenic
NC_000006.11:g.(?_158532398)_(162868359_?)del	deletion	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome [RCV003122912]\|not provided [RCV003122911]	Chr6:158532398..162868359 [GRCh37] Chr6:6q25.3-26	pathogenic\|no classifications from unflagged records
GRCh37/hg19 6q25.3-27(chr6:159121459-170919482)	copy number loss	Hydrocephalus [RCV002280751]	Chr6:159121459..170919482 [GRCh37] Chr6:6q25.3-27	pathogenic
GRCh37/hg19 6q25.3-27(chr6:157318401-165233548)x1	copy number loss	See cases [RCV002287557]	Chr6:157318401..165233548 [GRCh37] Chr6:6q25.3-27	pathogenic
NM_020133.3(AGPAT4):c.748C>G (p.His250Asp)	single nucleotide variant	not specified [RCV004311438]	Chr6:161149206 [GRCh38] Chr6:161570238 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.895A>G (p.Met299Val)	single nucleotide variant	not specified [RCV004331060]	Chr6:161139569 [GRCh38] Chr6:161560601 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.418G>A (p.Glu140Lys)	single nucleotide variant	not specified [RCV004141974]	Chr6:161154241 [GRCh38] Chr6:161575273 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.805G>A (p.Glu269Lys)	single nucleotide variant	not specified [RCV004195232]	Chr6:161146562 [GRCh38] Chr6:161567594 [GRCh37] Chr6:6q26	likely benign
NM_020133.3(AGPAT4):c.457A>C (p.Lys153Gln)	single nucleotide variant	not specified [RCV004242670]	Chr6:161154202 [GRCh38] Chr6:161575234 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.58G>C (p.Val20Leu)	single nucleotide variant	not specified [RCV004102147]	Chr6:161232156 [GRCh38] Chr6:161653188 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.772A>T (p.Ile258Phe)	single nucleotide variant	not specified [RCV004259372]	Chr6:161146595 [GRCh38] Chr6:161567627 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.904C>T (p.Pro302Ser)	single nucleotide variant	not specified [RCV004328753]	Chr6:161139560 [GRCh38] Chr6:161560592 [GRCh37] Chr6:6q26	uncertain significance
GRCh37/hg19 6q25.3-27(chr6:160952761-170892276)x1	copy number loss	not provided [RCV003334287]	Chr6:160952761..170892276 [GRCh37] Chr6:6q25.3-27	pathogenic
GRCh37/hg19 6q25.2-27(chr6:152853218-170914297)x1	copy number loss	See cases [RCV004442824]	Chr6:152853218..170914297 [GRCh37] Chr6:6q25.2-27	pathogenic
NM_020133.3(AGPAT4):c.128A>C (p.Lys43Thr)	single nucleotide variant	not specified [RCV004392318]	Chr6:161232086 [GRCh38] Chr6:161653118 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.596G>A (p.Arg199His)	single nucleotide variant	not specified [RCV004617910]	Chr6:161153414 [GRCh38] Chr6:161574446 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.1076C>T (p.Thr359Met)	single nucleotide variant	not specified [RCV004617918]	Chr6:161136601 [GRCh38] Chr6:161557633 [GRCh37] Chr6:6q26	uncertain significance
GRCh37/hg19 6q25.3-27(chr6:158471960-170919482)x1	copy number loss	not provided [RCV004819350]	Chr6:158471960..170919482 [GRCh37] Chr6:6q25.3-27	pathogenic
GRCh37/hg19 6q24.2-27(chr6:144561123-170919482)x3	copy number gain	not provided [RCV004819303]	Chr6:144561123..170919482 [GRCh37] Chr6:6q24.2-27	pathogenic
GRCh37/hg19 6q25.2-27(chr6:153777725-170919482)x1	copy number loss	not provided [RCV004819349]	Chr6:153777725..170919482 [GRCh37] Chr6:6q25.2-27	pathogenic
NM_020133.3(AGPAT4):c.969C>G (p.Phe323Leu)	single nucleotide variant	not specified [RCV004909986]	Chr6:161139495 [GRCh38] Chr6:161560527 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.799G>A (p.Asp267Asn)	single nucleotide variant	not specified [RCV004909990]	Chr6:161146568 [GRCh38] Chr6:161567600 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.833A>T (p.Tyr278Phe)	single nucleotide variant	not specified [RCV004922659]	Chr6:161146534 [GRCh38] Chr6:161567566 [GRCh37] Chr6:6q26	uncertain significance
NM_020133.3(AGPAT4):c.911G>A (p.Arg304Gln)	single nucleotide variant	not specified [RCV004920672]	Chr6:161139553 [GRCh38] Chr6:161560585 [GRCh37] Chr6:6q26	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	7411
Count of miRNA genes:	1342
Interacting mature miRNAs:	1752
Transcripts:	ENST00000320285, ENST00000366905, ENST00000366906, ENST00000366908, ENST00000366911, ENST00000436279, ENST00000437165, ENST00000457520
Prediction methods:	Microtar, Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597258269	GWAS1354343_H	triglyceride measurement, phospholipid measurement QTL GWAS1354343 (human)		1e-17	triglyceride measurement, phospholipid measurement	blood triglyceride level (CMO:0000118)	6	161239068	161239069	Human
597166237	GWAS1262311_H	triglyceride measurement QTL GWAS1262311 (human)		3e-20	non-high density lipoprotein cholesterol measurement	blood non-high density lipoprotein cholesterol level (CMO:0003967)	6	161238337	161238338	Human
597066782	GWAS1162856_H	fear of pain measurement QTL GWAS1162856 (human)		0.000001	fear-related behavior trait (VT:0010715)		6	161246020	161246021	Human
597307408	GWAS1403482_H	Alzheimer's disease biomarker measurement QTL GWAS1403482 (human)		0.000001	Alzheimer's disease biomarker measurement		6	161129967	161129968	Human
597274135	GWAS1370209_H	high density lipoprotein cholesterol measurement QTL GWAS1370209 (human)		1e-09	high density lipoprotein cholesterol measurement	blood high density lipoprotein cholesterol level (CMO:0000052)	6	161167340	161167341	Human
597157767	GWAS1253841_H	fatty acid measurement QTL GWAS1253841 (human)		6e-10	fatty acid measurement		6	161239068	161239069	Human
597316235	GWAS1412309_H	vaginal microbiome measurement QTL GWAS1412309 (human)		0.00001	vaginal microbiome measurement		6	161201574	161201575	Human
597265035	GWAS1361109_H	total cholesterol measurement QTL GWAS1361109 (human)		6e-23	total cholesterol measurement	blood total cholesterol level (CMO:0000051)	6	161238337	161238338	Human
1643404	BMD3_H	Bone mineral density QTL 3 (human)	2.42	0.0005	Bone mineral density		6	157563614	170805979	Human
407123538	GWAS772514_H	anxiety QTL GWAS772514 (human)		0.000008	anxiety		6	161254459	161254460	Human
597240832	GWAS1336906_H	lipoprotein A measurement QTL GWAS1336906 (human)		1e-88	lipoprotein A measurement		6	161207628	161207629	Human
597157899	GWAS1253973_H	fatty acid measurement QTL GWAS1253973 (human)		2e-09	fatty acid measurement		6	161139429	161139430	Human
597245316	GWAS1341390_H	lipoprotein A measurement QTL GWAS1341390 (human)		5e-511	lipoprotein A measurement		6	161139429	161139430	Human
597153206	GWAS1249280_H	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1249280 (human)		2e-14	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	blood low density lipoprotein cholesterol level (CMO:0000053)	6	161238337	161238338	Human
597446456	GWAS1542530_H	lipoprotein A measurement QTL GWAS1542530 (human)		1e-11	lipoprotein A measurement		6	161144148	161144149	Human
597156912	GWAS1252986_H	fatty acid measurement QTL GWAS1252986 (human)		5e-08	fatty acid measurement		6	161238337	161238338	Human
597243838	GWAS1339912_H	lipoprotein A measurement QTL GWAS1339912 (human)		4e-18	lipoprotein A measurement		6	161245158	161245159	Human
597285425	GWAS1381499_H	cardiovascular disease QTL GWAS1381499 (human)		5e-09	cardiovascular disease		6	161238337	161238338	Human
597326771	GWAS1422845_H	non-high density lipoprotein cholesterol measurement QTL GWAS1422845 (human)		4e-24	non-high density lipoprotein cholesterol measurement	blood non-high density lipoprotein cholesterol level (CMO:0003967)	6	161238337	161238338	Human
597602611	GWAS1659471_H	type 2 diabetes mellitus QTL GWAS1659471 (human)		3e-08	type 2 diabetes mellitus		6	161273147	161273148	Human
597160760	GWAS1256834_H	factor VIII measurement, coronary artery disease QTL GWAS1256834 (human)		9e-16	factor XI measurement, coronary artery disease		6	161130144	161130145	Human
597157669	GWAS1253743_H	fatty acid measurement QTL GWAS1253743 (human)		1e-09	fatty acid measurement		6	161239068	161239069	Human
597240234	GWAS1336308_H	lipoprotein A measurement QTL GWAS1336308 (human)		3e-53	lipoprotein A measurement		6	161186098	161186099	Human
597323310	GWAS1419384_H	low density lipoprotein cholesterol measurement QTL GWAS1419384 (human)		1e-32	low density lipoprotein cholesterol measurement	blood low density lipoprotein cholesterol level (CMO:0000053)	6	161238337	161238338	Human
597165229	GWAS1261303_H	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement QTL GWAS1261303 (human)		8e-12	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	blood low density lipoprotein cholesterol level (CMO:0000053)	6	161238337	161238338	Human
597240239	GWAS1336313_H	lipoprotein A measurement QTL GWAS1336313 (human)		2e-45	lipoprotein A measurement		6	161135561	161135562	Human
597240608	GWAS1336682_H	lipoprotein A measurement QTL GWAS1336682 (human)		9e-160	lipoprotein A measurement		6	161234325	161234326	Human
597240229	GWAS1336303_H	lipoprotein A measurement QTL GWAS1336303 (human)		3e-60	lipoprotein A measurement		6	161187220	161187221	Human
597266009	GWAS1362083_H	low density lipoprotein cholesterol measurement QTL GWAS1362083 (human)		3e-41	low density lipoprotein cholesterol measurement	blood low density lipoprotein cholesterol level (CMO:0000053)	6	161238337	161238338	Human
597157331	GWAS1253405_H	triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1253405 (human)		3e-08	triglyceride measurement, low density lipoprotein cholesterol measurement	blood low density lipoprotein cholesterol level (CMO:0000053)	6	161139429	161139430	Human
597312479	GWAS1408553_H	vaginal microbiome measurement QTL GWAS1408553 (human)		0.0000007	vaginal microbiome measurement		6	161201574	161201575	Human
597240415	GWAS1336489_H	lipoprotein A measurement QTL GWAS1336489 (human)		1e-24	lipoprotein A measurement		6	161265760	161265761	Human
597240414	GWAS1336488_H	lipoprotein A measurement QTL GWAS1336488 (human)		1e-24	lipoprotein A measurement		6	161130844	161130845	Human
597259984	GWAS1356058_H	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1356058 (human)		7e-16	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	blood low density lipoprotein cholesterol level (CMO:0000053)	6	161238337	161238338	Human
597151175	GWAS1247249_H	osteoarthritis, hand QTL GWAS1247249 (human)		0.000006	osteoarthritis, hand		6	161249732	161249733	Human
597151174	GWAS1247248_H	osteoarthritis, hand QTL GWAS1247248 (human)		0.000005	osteoarthritis, hand		6	161248199	161248200	Human
597151173	GWAS1247247_H	osteoarthritis, hand QTL GWAS1247247 (human)		0.000005	osteoarthritis, hand		6	161247713	161247714	Human
597151172	GWAS1247246_H	osteoarthritis, hand QTL GWAS1247246 (human)		0.000006	osteoarthritis, hand		6	161245733	161245734	Human
597066562	GWAS1162636_H	lipoprotein A measurement, apolipoprotein A 1 measurement QTL GWAS1162636 (human)		8e-09	lipoprotein A measurement, apolipoprotein A 1 measurement	blood apolipoprotein AI level (CMO:0000520)	6	161233083	161233084	Human
597151171	GWAS1247245_H	osteoarthritis, hand QTL GWAS1247245 (human)		0.000009	osteoarthritis, hand		6	161245158	161245159	Human
597311567	GWAS1407641_H	vaginal microbiome measurement QTL GWAS1407641 (human)		0.000009	vaginal microbiome measurement		6	161201574	161201575	Human
597166285	GWAS1262359_H	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1262359 (human)		5e-18	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	blood low density lipoprotein cholesterol level (CMO:0000053)	6	161239068	161239069	Human
597243852	GWAS1339926_H	lipoprotein A measurement QTL GWAS1339926 (human)		2e-10	lipoprotein A measurement		6	161240453	161240454	Human
597066691	GWAS1162765_H	fear of minor pain measurement QTL GWAS1162765 (human)		3e-08	fear-related behavior trait (VT:0010715)		6	161246020	161246021	Human
597171023	GWAS1267097_H	angiostatin measurement QTL GWAS1267097 (human)		1e-27	angiostatin measurement		6	161211987	161211988	Human
597158095	GWAS1254169_H	fatty acid measurement QTL GWAS1254169 (human)		4e-09	fatty acid measurement		6	161239068	161239069	Human
597266368	GWAS1362442_H	high density lipoprotein cholesterol measurement QTL GWAS1362442 (human)		2e-11	high density lipoprotein cholesterol measurement	blood high density lipoprotein cholesterol level (CMO:0000052)	6	161167340	161167341	Human
597166145	GWAS1262219_H	triglyceride measurement, low density lipoprotein cholesterol measurement QTL GWAS1262219 (human)		1e-20	triglyceride measurement, low density lipoprotein cholesterol measurement	blood low density lipoprotein cholesterol level (CMO:0000053)	6	161238337	161238338	Human
597349318	GWAS1445392_H	myocardial infarction QTL GWAS1445392 (human)		1e-09	myocardial infarction		6	161261537	161261538	Human
597256775	GWAS1352849_H	total cholesterol measurement QTL GWAS1352849 (human)		7e-30	total cholesterol measurement	blood total cholesterol level (CMO:0000051)	6	161238337	161238338	Human
597151177	GWAS1247251_H	osteoarthritis, hand QTL GWAS1247251 (human)		0.000006	osteoarthritis, hand		6	161257709	161257710	Human
597151176	GWAS1247250_H	osteoarthritis, hand QTL GWAS1247250 (human)		0.000005	osteoarthritis, hand		6	161250371	161250372	Human
597263356	GWAS1359430_H	triglyceride measurement, high density lipoprotein cholesterol measurement QTL GWAS1359430 (human)		3e-10	triglyceride measurement, high density lipoprotein cholesterol measurement	blood high density lipoprotein cholesterol level (CMO:0000052)	6	161238337	161238338	Human
597288958	GWAS1385032_H	angina pectoris QTL GWAS1385032 (human)		2e-09	angina pectoris		6	161238337	161238338	Human
597245417	GWAS1341491_H	low density lipoprotein cholesterol measurement QTL GWAS1341491 (human)		1e-15	myocardial infarction	blood low density lipoprotein cholesterol level (CMO:0000053)	6	161130144	161130145	Human
597254376	GWAS1350450_H	apolipoprotein B measurement QTL GWAS1350450 (human)		2e-15	apolipoprotein B measurement	blood apoliprotein B level (CMO:0000522)	6	161130144	161130145	Human
597309673	GWAS1405747_H	vaginal microbiome measurement QTL GWAS1405747 (human)		0.000006	vaginal microbiome measurement		6	161201574	161201575	Human
597223660	GWAS1319734_H	total cholesterol measurement QTL GWAS1319734 (human)		2e-12	total cholesterol measurement	blood total cholesterol level (CMO:0000051)	6	161130144	161130145	Human
596976224	GWAS1095743_H	cardiovascular disease QTL GWAS1095743 (human)		5e-09	cardiovascular disease		6	161238337	161238338	Human
597165933	GWAS1262007_H	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio QTL GWAS1262007 (human)		2e-18	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	blood low density lipoprotein cholesterol level (CMO:0000053)	6	161239068	161239069	Human
597240032	GWAS1336106_H	lipoprotein A measurement QTL GWAS1336106 (human)		7e-33	lipoprotein A measurement		6	161133692	161133693	Human
407041598	GWAS690574_H	lipoprotein A measurement QTL GWAS690574 (human)		3e-08	lipoprotein A measurement		6	161130407	161130408	Human
1643367	BW323_H	Body weight QTL 323 (human)	2.42	0.0005	Body fat amount		6	157563614	170805979	Human
597240423	GWAS1336497_H	lipoprotein A measurement QTL GWAS1336497 (human)		1e-22	lipoprotein A measurement		6	161130144	161130145	Human
597242983	GWAS1339057_H	lipoprotein A measurement QTL GWAS1339057 (human)		8e-263	lipoprotein A measurement		6	161145653	161145654	Human
596979307	GWAS1098826_H	angina pectoris QTL GWAS1098826 (human)		2e-09	angina pectoris		6	161238337	161238338	Human

RH63713

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	6	161,585,978 - 161,586,122	UniSTS	GRCh37
Build 36	6	161,505,968 - 161,506,112	RGD	NCBI36
Celera	6	162,315,378 - 162,315,522	RGD
Cytogenetic Map	6	q26	UniSTS
HuRef	6	159,041,340 - 159,041,484	UniSTS
GeneMap99-GB4 RH Map	6	636.32	UniSTS
NCBI RH Map	6	1631.6	UniSTS

SHGC-105981

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	6	161,655,494 - 161,655,805	UniSTS	GRCh37
Build 36	6	161,575,484 - 161,575,795	RGD	NCBI36
Celera	6	162,384,892 - 162,385,203	RGD
Cytogenetic Map	6	q26	UniSTS
HuRef	6	159,111,172 - 159,111,483	UniSTS
TNG Radiation Hybrid Map	6	29935.0	UniSTS

WI-13958

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	6	161,557,167 - 161,557,294	UniSTS	GRCh37
Build 36	6	161,477,157 - 161,477,284	RGD	NCBI36
Celera	6	162,286,567 - 162,286,694	RGD
Cytogenetic Map	6	q26	UniSTS
HuRef	6	159,012,528 - 159,012,655	UniSTS
GeneMap99-GB4 RH Map	6	628.21	UniSTS
Whitehead-RH Map	6	833.8	UniSTS
NCBI RH Map	6	1631.6	UniSTS

RH46750

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	6	161,557,188 - 161,557,356	UniSTS	GRCh37
Build 36	6	161,477,178 - 161,477,346	RGD	NCBI36
Celera	6	162,286,588 - 162,286,756	RGD
Cytogenetic Map	6	q26	UniSTS
HuRef	6	159,012,549 - 159,012,717	UniSTS
GeneMap99-GB4 RH Map	6	626.5	UniSTS
NCBI RH Map	6	1631.6	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2419	2788	2249	4973	1725	2344	6	623	1936	464	2269	7281	6461	53	3734	1	852	1742	1611	175	1


RefSeq Transcripts	NM_020133	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_005267053	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_006715514	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017011059	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_001743516	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AF156776	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AJ227890	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AJ227891	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AJ420473	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK074208	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK295025	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK295548	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK295826	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK297636	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK299721	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL109942	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL122123	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL832128	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AX119047	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AY358506	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC013410	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC020209	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BQ072907	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471051	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068272	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CR627395	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KF458354	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000320285 ⟹ ENSP00000314036

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	6	161,129,967 - 161,274,061 (-)	Ensembl

Ensembl Acc Id:

ENST00000366905 ⟹ ENSP00000355872

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	6	161,165,838 - 161,274,032 (-)	Ensembl

Ensembl Acc Id:

ENST00000366911 ⟹ ENSP00000355878

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	6	161,129,979 - 161,274,025 (-)	Ensembl

Ensembl Acc Id:

ENST00000436279 ⟹ ENSP00000413901

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	6	161,149,205 - 161,232,236 (-)	Ensembl

Ensembl Acc Id:

ENST00000437165 ⟹ ENSP00000400211

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	6	161,143,956 - 161,149,289 (-)	Ensembl

Ensembl Acc Id:

ENST00000624499

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	6	161,160,105 - 161,273,963 (-)	Ensembl

RefSeq Acc Id:

NM_020133 ⟹ NP_064518

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	6	161,129,967 - 161,274,061 (-)	NCBI
GRCh37	6	161,551,057 - 161,695,107 (-)	RGD
Build 36	6	161,471,047 - 161,615,097 (-)	NCBI Archive
Celera	6	162,280,457 - 162,424,409 (-)	RGD
HuRef	6	159,006,418 - 159,150,408 (-)	ENTREZGENE
CHM1_1	6	161,813,702 - 161,957,597 (-)	NCBI
T2T-CHM13v2.0	6	162,488,365 - 162,632,384 (-)	NCBI

Sequence:

show sequence

GCTTTTTCTTTCCAGTGTTGGCTGACTTACAGCTCTTATAAACTAGTGGCAATTTCTGAACCCAGCCGGCTCCATCTCAGCTTCTGGTTTCTAAGTCCATGTGCCAAAGGCTGCCAGGAAGGAGACGC
CTTCCTGAGTCCTGGATCTTTCTTCCTTCTGGAAATCTTTGACTGTGGGTAGTTATTTATTTCTGAATAAGAGCGTCCACGCATCATGGACCTCGCGGGACTGCTGAAGTCTCAGTTCCTGTGCCACC
TGGTCTTCTGCTACGTCTTTATTGCCTCAGGGCTAATCATCAACACCATTCAGCTCTTCACTCTCCTCCTCTGGCCCATTAACAAGCAGCTCTTCCGGAAGATCAACTGCAGACTGTCCTATTGCATC
TCAAGCCAGCTGGTGATGCTGCTGGAGTGGTGGTCGGGCACGGAATGCACCATCTTCACGGACCCGCGCGCCTACCTCAAGTATGGGAAGGAAAATGCCATCGTGGTTCTCAACCACAAGTTTGAAAT
TGACTTTCTGTGTGGCTGGAGCCTGTCCGAACGCTTTGGGCTGTTAGGGGGCTCCAAGGTCCTGGCCAAGAAAGAGCTGGCCTATGTCCCAATTATCGGCTGGATGTGGTACTTCACCGAGATGGTCT
TCTGTTCGCGCAAGTGGGAGCAGGATCGCAAGACGGTTGCCACCAGTTTGCAGCACCTCCGGGACTACCCCGAGAAGTATTTTTTCCTGATTCACTGTGAGGGCACACGGTTCACGGAGAAGAAGCAT
GAGATCAGCATGCAGGTGGCCCGGGCCAAGGGGCTGCCTCGCCTCAAGCATCACCTGTTGCCACGAACCAAGGGCTTCGCCATCACCGTGAGGAGCTTGAGAAATGTAGTTTCAGCTGTATATGACTG
TACACTCAATTTCAGAAATAATGAAAATCCAACACTGCTGGGAGTCCTAAACGGAAAGAAATACCATGCAGATTTGTATGTTAGGAGGATCCCACTGGAAGACATCCCTGAAGACGATGACGAGTGCT
CGGCCTGGCTGCACAAGCTCTACCAGGAGAAGGATGCCTTTCAGGAGGAGTACTACAGGACGGGCACCTTCCCAGAGACGCCCATGGTGCCCCCCCGGCGGCCCTGGACCCTCGTGAACTGGCTGTTT
TGGGCCTCGCTGGTGCTCTACCCTTTCTTCCAGTTCCTGGTCAGCATGATCAGGAGCGGGTCTTCCCTGACGCTGGCCAGCTTCATCCTCGTCTTCTTTGTGGCCTCCGTGGGAGTTCGATGGATGAT
TGGTGTGACGGAAATTGACAAGGGCTCTGCCTACGGCAACTCTGACAGCAAGCAGAAACTGAATGACTGACTCAGGGAGGTGTCACCATCCGAAGGGAACCTTGGGGAACTGGTGGCCTCTGCATATC
CTCCTTAGTGGGACACGGTGACAAAGGCTGGGTGAGCCCCTGCTGGGCACGGCGGAAGTCACGACCTCTCCAGCCAGGGAGTCTGGTCTCAAGGCCGGATGGGGAGGAAGATGTTTTGTAATCTTTTT
TTCCCCATGTGCTTTAGTGGGCTTTGGTTTTCTTTTTGTGCGAGTGTGTGTGAGAATGGCTGTGTGGTGAGTGTGAACTTTGTTCTGTGATCATAGAAAGGGTATTTTAGGCTGCAGGGGAGGGCAGG
GCTGGGGACCGAAGGGGACAAGTTCCCCTTTCATCCTTTGGTGCTGAGTTTTCTGTAACCCTTGGTTGCCAGAGATAAAGTGAAAAGTGCTTTAGGTGAGATGACTAAATTATGCCTCCAAGAAAAAA
AAATTAAAGTGCTTTTCTGGGTCATCTGTGGTGTATGTTGACATGGACCGCTGCCCCTCCATCCTGCCCTTGCCCGTGGCTTTGGTGTTTCAGATCCTACTCACGGGAGGCAGCTGCCGCGGAGGTGT
GGGCAGCTGAGAGGGGTGGGCAGGCCAGCACAGCTCCTGGCAGGAGACACAGGTCCAGGAGCCCGTGAGCATTTGTGAGAGCAGAGATGGCAAGCACGTGCGTGGAGACCAACGAAGCGTGTCCCTGG
CACACAGCAAGGGAGAGTTTCGCTCGGTCTCTGCAGTGCAGTCTCCTGGCGTAAGTCTTGAAGATGGACCCAACTCCCTGAAGAAATGGATCTTGAAATTGAACACAAACATCATGAACGTACAGCCT
GGGCATTCTGCAGTGATTTGTGAGATGAGCTTGCATCGACTGTTCCTCTCAGCAGTGACAGCCAAAGTCACCCCTGATAAAATGCAGTTTCACTTTATAAAATGCCTCGCCCCTTCCCAGCATGTAGA
GCTTGTCTGCAGCCCTAAAGGAGCCAGGTCCTGCTCTGATGAGGGTCAAATCAGAGCCGACATCCCATGTACAAAAAACCCCCAGGCTTCTGCCTTCCTTCCGGGCTCCTGTCTGCTCCCATTTTACT
CCACGGAATAGTTCTGCCCTGTAGCATCTCCAGCGGCCTTTGCAGACTGCTGTCAGCCAACAGGTGCCAAAAATGCAAAAGAAGAAGAAACTAAAAGCAGTGCTATTTTTGCAGAACAAATGCTAGCT
ATTAAATCATCTTAGGCCAAGACACCAATGGCACTTGGACCGATAGGTATTTGGAGCATGAGTTAGGAAGGATATGTCTTTCTCCAGGTGCGCAGCTGAAAGTTGCTGAGAAAAGCTGCCTGTGTTGC
TGTGGTAACATGAGAAGGAATGAACAGCTCTATACAAAAACTGGCCACACATTATAAGGCCTATTCTATGCAGTTATGTTTTTGGCTATTTGCTCATTTAGTCATTGTTTATCAACCAAACTAGGTAA
GCCAAGGAGTTACAAGACAGCTCTAGAGAAGCTCCCTCTGCTTACAGGACAATAATGCATTGTTTGTTTGTTGATACAAATGAATTATTTGAATCCACAGAAGTGAAAAAGGGAAAAAATCCTGGCTG
ACTTGTGGGAAGAGCGTACTGCAGAGCCTAGGGCCTGAGTTAACTCGCTGGCGGCCCTGCAGGCAGGCTTGATGGGAGCGCCCAGCACATCTGCCCACCCTGCACAGGGCATGAAGCACCGTGTGCAG
AGATCTGTGGGCAAAAGCCCAGGACGTGACCTTAGGCAAGAGGGGTCCTTGGAGAAGTGGAGGTGTGCATGGTGTGTAGCCTTGCGTGTCTGTGAGCACGCCCTAGTGGACCTGCGCCTGGATTATCG
GGCCAGTCTCTCGGAGGGGTCCGTGATGCTGAGTTACGCCATTCACCTGAACTCTGCAGCTCATCGGCTGTAGGATTTGGGTGAGACACTTTTCCTTGCTGACTCATTTCCCCATCTGCAAAATGGGG
GTGACGATATCTACCTCTTGGGGTGTGTCAAGGGTAAAAGAGCACACTTTAAGAATCCTAAAGCACTAAGCCAAGGATGAAAGACTAGAAAGCTGCCTCTATGTTGCTACTCTCAAAAATGCTCAGAA
ATTTTCTTGTCGTACTAAAAATGTGTTATTTTTCTCATTTTCATTCTTCCATTCAACACAGAAGTAATCTAAGTAAGTTCTAAAAACATAGATCCGGGGGCCCACAGACATTCAATTTTCTTCTGAAT
TGGCTCTGGTATCACACAACACACAAGCAAGCAAACAGCCTGCCTGCTAGGGCCTTGGGTTCCAGGCTGGAGGAATGCAGGCAGAAATCTCTTAGGAAATAACTAAGTGAGCGCCAAGTTTTGAATTG
CCTTAGAGCCGAAAGAGAATGTGGCGTGCTGGGGAGAGATCTGGACCTCTTTCTCATCAGTCATTTGACCTGTCCACGAAGAACAATTTTGTTATGCAGCCTGGGAACCTGGTTTCCTTACACCCTGC
GCCCTTAATGACACAGACAACCACGGGTACTCCTGGACGGAAGCTCATCACGCCTCCTCAAATACCTTCACCCATGTTCAGGTCACACGGAGGTCACCATCTCCTCAGCACACAACAACTGCTTTGGT
TCCCAGGGTTATTTTTTCTACGAGTTGAAAACCCACGGAGCCTAAGCCATCTTTTTGTCCCCTAAGGAGAGCCCCATAGACTAAGAGCTACACTTCCTGTCTGTCTTTCCCACCTTTCCATCTCATTC
TAGCTTAAAGCTTATCACGCTACTGAGAGCCTGTTCTGTAGTTCAAGGTGGCAGAGAAAAATACGAACCTTGAGTGAAATCTGGAGAGCAGTGCAGGGTCATCCCCAGACGTGACGGGCCATATCCTA
GGCGACTCCTGCAGCTTATAGAAGCAGGGAATTTAATGGACTTCTTCCAGGAAAGCCAGCCCACGGGGACTCTTAAAAAGACACCAACCATTTGGAAGATGCAGCTTGAGGTCTGGGGGACTGGACTG
ATTCTGCCACCATATAGTGAACACGATTAATCGGGAGGAAGAAGTAAGGCACTCTGTGAGTTAGTCTACCACCCTATTGACTTTGACAGAGAGAAAACCAACTTTTTTCATATGATCACACAGTAGTA
CTGGAATATCTCGACTGCAATATCCTCTAAACAAATGCATGCAAAGCTTTGTAAAAGCAGCTGATGATTAAAAAAATTTTAAAACATTAGGGTTTTTCTAATATATCCATATGTGGGACAGTGATTTA
AATGTCATTAATTGTCCAGCCACAACTTGTAACAGTGATGTGAAAGACACAAAAAAGGCCCCACTGGAGTGGAGGAGTGGTCTGGCTGGTCCCCAAGCAAAACAGAATGGGCTTCGCATAGGCTTTAG
AACTTATTCATAAATATTGACCAAAGTGTGAAGCAAGGTATCCAGTGAAGATTCTCTAGGGTCTCTACTTCTGCTCAAGAGATTTAATCCAGCTTTCTCTAAAGCAGTGGTCCAGACTTGCCACATAC
TAGGTTAAAGATAAAGTGAGAAAAACAAATACTTTGGTTTGCACGTCTCTTGAGGGGCCCTAGGCTGTATGGAGGAATATTTAGAGGAATATTTGTGAGCTGCCATTTGTGTTTAAAAGAACATGAAA
GCAAGACGGGCCCTAACCCGCCTGTGTCTGTAGCTGACCAGGAGGCCACTGCTTCCTTCCCCCAGAGCTTCTAGGAGAGCCCCCCAAAATGCAACTCTCCAAGGTCCTGTGGAGTAGTCCCCTCATAA
TGCCTCCACCACACCTGTGTCTCACGATGCCTTAACTGACGTAGCTCCTAAGTGATGTTCACAGAGAAGGAAATACTTAGGCAAGCCCATGTGTAACATGCTCACAGATGTGCTGGCTTTGCCAATGC
TTTCGGACTCCACCATGCTTTCTGATTCTTCTGGTCCTAGTCACGCCTTGGCACGGGGCAGAAGCGGCCGAGCTATGCTGACAGGTGCTGCTGAGAGCCAACAGCCATTCAGCCGAGAAGGCGTTTCT
AGGTGAGGGCATGAGAGCTGGCATTCCAGGCTGCTGAGTGCGGCATCTGCAGGTGCACCACATTGCTCCACGGTGTGTTCAGAAGAGACCAGCATCTTGAATCTCAGGCTCTGGGCTCATTCTTTGCC
TCTGCCAAGGGACCATTCAGGGGCTTCAAGCCAGCTGCTGAAAATCCCCCTTTTCTGGATTTTTCCCCATCTATATAAGGATATGGTGGCTGTGTGGACAAGAAATTGGTTTCATCTCAGAAGGGTGC
TTCCCTACAAAGATCTTCAGAAATTTAATTGAAAACAATTTTTTGAACTTTTTTTGTTTGGCCAGGATGAATGAAGCTGAAGTCACATCCTGAATGTGCATGCCAGACAAAGGGTAAGCAAGCAGTCT
TTACAAATGCCAATCCCTCTGCACTCCAAAACCGGAGCCCGTAATGAAGGCCCAGGTTCCAGTCATCACAGGATCCCCCAAGCCAGCACAGTGCCTGATGCCTCCCTAGGCATTAGCACATCCCAGCA
CTCTAATTCACATCCTCAGCATCCCTGCCTCCTGCATCCAGGGCTTAGGTTGAGTGTTTCCAGAGTGTCAAGTACATTTAAACACAAACCAAATACTCCAGGGTTTTGACCTGTCACAATGGCTTTTG
AAAACAACAGACGTACAATTTGAGAGAAGGACTCGATGGACTTCTTAGGCTGAGGACTAAGGACATGTTGCTGTTCCTCTTGGTCCAGGACATTCAATACCATTCACAGCATTCATCACCAACTGACA
TAGTATCGATCACGACATTCAACTGTTTGAAATTACTGCTATTTTGGTCAAAAACTAAGAAATCAGAAATTGCACCTACATAGTGTGTCTCCTCATTGGAGTCCCATCTCTCTGAGCACAGGGATGGG
CTCCTGAGCTCACAGCCCTGCCCTGCCCCCCCAGCAGGGCCTCACCCTCATGGCCCTCAGTGAATAGTGACTACATGAAGGGGGCACTTACTAGAGGCCTGAGTAATGGAATTTCAATTAGCTTCTGC
TTCCCTTTTCTAAAAAAGAACCACCTTTCTTAAGAATAATTAGGCCAAAATAAACTTGAGTAATTTGTACAGTCAATATTTTGAAGTTTCGGAGTTACCAGTGAAATAGCAAAGCTGTTCTCCAGGAA
AGGACATCCAGGTTCCCACCCAGGCCTTCCTTCCTCAGCTCCTGCAGCCTCATCCTAGTTTAATATGAAGGTTGTGAATGGGTTAAAAAGCAGTTCTTAAGCACCTACTTAGATCTTTTCAGTATCTG
GAAATAGCACCCAGGGCTGTGTTAGTAAAGCTTTTCACTGGGTAAGAGTCATACAATTTTTACATTTAATTTGTTTTTTTAAAACAAGGCAGTCTTGTTTTACATATTGGAATGACTAGATATTTTTT
GACATTTCTGGCACCTCTGGTTCTGCTGAATTTTAAGGGAGGTGAGTGGTATGTACACAAAGTTAAGATTGCTGCATAATAATTCCTTTGCATTTCCAAAATAAATTACACAAATGTCACTTTTCCTT
TTCTATTCCATAGTACTAGTTTTAGCCAGATCTTTGCCAAACATTCTAGGACATTCAGAAAAGTCATCCATGGAATTTTGGAATGCCATTCTCTCTGTATCTTTGCAGATCATGAGGAAGGAAAGTTG
ATGAACTAGTACGGGATGGCTCAGACTTGTAAAGTGTCTAAGTCACAACGCTGCAGAGCCAGCTTCCGGGTAGCAATGGCATGGCCTCAGCTGTGCCAAGGCTACAACTGGAGCTTCCTTACTCGCAT
CTGAGGCAAACACAGCAAGGCTGGCCCAGGCCGCCCACAGTCAACAGATGTTCACGGGAGATGGATCAGCCCCTCTTTTGCTTGTTCTATCAAGGAAAGAGATCTAACCATGGGCAAGGGTGGAACAC
ACCCGGTTCAGGTCAGGGAATGAGTTGCTCTAAGTGAACAGTGAATTCTTACTTCTCAGCCTGTATCAATTGTACCCAGGGTTCATGATTACTGTGACCCACTAAGGGATGATCTTTGAGGAAACAGA
CCTGGAGGGAGGTAATTTAAGGAGGGAAAGCGAGTGGGTTTTACAGACTGCTTTGTGGCGACATTCAGGAACAGACCATTCAATGGATGACTTTTCAGTACATAAAAGCAAGCAGTAATGGCCAGGAG
AGAGCAAAGATGCCCTAAGAATGACATCAGACTGACCAAATGTGCCTTTTCAAATAAGTTATGAGAACGAATGAATTGGAATTAGAGCAAGGTATTGGACAGAACCATGCTAGTCTTTGAGAGAACGT
GTGGATTGGGTGGATGTTTGGACCGAATGAATGGTAACTTTTTAATGTGAAACAGAGAACTGATATATGGGCTGTCATGTCACCCTAGGGTACTGTCGCTCTGTCATGTGTAGCAATCTTTCCAAATT
TTTGTTGGTGGGCTGAACAAAGATAAAACTAATAAAGTATGTGTGGATACCACTAGACAGCACAGCTTACTGGACTGGATGTAATAAAACTGACTGAAACTTTAACTTGGAAAAA

hide sequence


Protein RefSeqs	NP_064518	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAF80338	(Get FASTA)	NCBI Sequence Viewer
	AAH13410	(Get FASTA)	NCBI Sequence Viewer
	AAH20209	(Get FASTA)	NCBI Sequence Viewer
	AAQ88870	(Get FASTA)	NCBI Sequence Viewer
	BAG58081	(Get FASTA)	NCBI Sequence Viewer
	BAG58454	(Get FASTA)	NCBI Sequence Viewer
	BAG58643	(Get FASTA)	NCBI Sequence Viewer
	BAG60008	(Get FASTA)	NCBI Sequence Viewer
	BAG61621	(Get FASTA)	NCBI Sequence Viewer
	CAC38597	(Get FASTA)	NCBI Sequence Viewer
	CAH10489	(Get FASTA)	NCBI Sequence Viewer
	EAW47577	(Get FASTA)	NCBI Sequence Viewer
	EAW47578	(Get FASTA)	NCBI Sequence Viewer
	EAW47579	(Get FASTA)	NCBI Sequence Viewer
	EAW47580	(Get FASTA)	NCBI Sequence Viewer
	EAW47581	(Get FASTA)	NCBI Sequence Viewer
	EAW47582	(Get FASTA)	NCBI Sequence Viewer
	EAW47583	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000314036
	ENSP00000314036.4
GenBank Protein	Q9NRZ5	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_064518 ⟸ NM_020133

- UniProtKB:

B4DSF9 (UniProtKB/Swiss-Prot), Q5TEF0 (UniProtKB/Swiss-Prot), Q9NRZ5 (UniProtKB/Swiss-Prot)

- Sequence:

show sequence

MDLAGLLKSQFLCHLVFCYVFIASGLIINTIQLFTLLLWPINKQLFRKINCRLSYCISSQLVMLLEWWSGTECTIFTDPRAYLKYGKENAIVVLNHKFEIDFLCGWSLSERFGLLGGSKVLAKKELAY
VPIIGWMWYFTEMVFCSRKWEQDRKTVATSLQHLRDYPEKYFFLIHCEGTRFTEKKHEISMQVARAKGLPRLKHHLLPRTKGFAITVRSLRNVVSAVYDCTLNFRNNENPTLLGVLNGKKYHADLYVR
RIPLEDIPEDDDECSAWLHKLYQEKDAFQEEYYRTGTFPETPMVPPRRPWTLVNWLFWASLVLYPFFQFLVSMIRSGSSLTLASFILVFFVASVGVRWMIGVTEIDKGSAYGNSDSKQKLND

hide sequence

Ensembl Acc Id:

ENSP00000314036 ⟸ ENST00000320285

Ensembl Acc Id:

ENSP00000355878 ⟸ ENST00000366911

Ensembl Acc Id:

ENSP00000355872 ⟸ ENST00000366905

Ensembl Acc Id:

ENSP00000413901 ⟸ ENST00000436279

Protein Domains

Acyltransferase C-terminal Phospholipid/glycerol acyltransferase

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q9NRZ5-F1-model_v2	AlphaFold	Q9NRZ5	1-378	view protein structure

RGD ID:

7209619

Promoter ID:

EPDNEW_H10555

Type:

initiation region

Name:

AGPAT4_1

Description:

1-acylglycerol-3-phosphate O-acyltransferase 4

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	6	161,274,061 - 161,274,121	EPDNEW

RGD ID:

6803992

Promoter ID:

HG_KWN:55706

Type:

Non-CpG

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, K562, Lymphoblastoid, NB4

Transcripts:

ENST00000366905, ENST00000366906, ENST00000366908, NM_020133, UC003QTS.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	6	161,614,891 - 161,615,391 (-)	MPROMDB

Database	Acc Id	Source(s)
COSMIC	AGPAT4	COSMIC
Ensembl Genes	ENSG00000026652	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000320285	ENTREZGENE
	ENST00000320285.9	UniProtKB/Swiss-Prot
GTEx	ENSG00000026652	GTEx
HGNC ID	HGNC:20885	ENTREZGENE
Human Proteome Map	AGPAT4	Human Proteome Map
InterPro	Acyltransf_C	UniProtKB/Swiss-Prot
	Plipid/glycerol_acylTrfase	UniProtKB/Swiss-Prot
KEGG Report	hsa:56895	UniProtKB/Swiss-Prot
NCBI Gene	56895	ENTREZGENE
OMIM	614795	OMIM
PANTHER	1-ACYL-SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE DELTA	UniProtKB/Swiss-Prot
	1-ACYLGLYCEROL-3-PHOSPHATE ACYLTRANSFERASE-RELATED	UniProtKB/Swiss-Prot
Pfam	Acyltransf_C	UniProtKB/Swiss-Prot
	Acyltransferase	UniProtKB/Swiss-Prot
PharmGKB	PA134961047	PharmGKB
SMART	PlsC	UniProtKB/Swiss-Prot
Superfamily-SCOP	Glycerol-3-phosphate (1)-acyltransferase	UniProtKB/Swiss-Prot
UniProt	B4DHC0_HUMAN	UniProtKB/TrEMBL
	B4DSF9	ENTREZGENE
	G3XAF1_HUMAN	UniProtKB/TrEMBL
	H0Y5R3_HUMAN	UniProtKB/TrEMBL
	PLCD_HUMAN	UniProtKB/Swiss-Prot
	Q5TEE8_HUMAN	UniProtKB/TrEMBL
	Q5TEF0	ENTREZGENE
	Q6AI25_HUMAN	UniProtKB/TrEMBL
	Q6PJN9_HUMAN	UniProtKB/TrEMBL
	Q9NRZ5	ENTREZGENE
UniProt Secondary	B4DSF9	UniProtKB/Swiss-Prot
	Q5TEF0	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2013-02-12	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4	AGPAT4	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Send us a Message

Imported Disease Annotations - ClinVar

Imported Annotations - KEGG (archival)